KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Sep 11, 2026 >>  ABB India 7269.1  [ -0.83% ]  ACC 1246.15  [ -0.70% ]  Ambuja Cements 391  [ -1.26% ]  Asian Paints 2470  [ -0.40% ]  Axis Bank 1247.5  [ -0.99% ]  Bajaj Auto 11684  [ -1.07% ]  Bank of Baroda 237.8  [ -0.08% ]  Bharti Airtel 1832  [ -0.27% ]  Bharat Heavy 430.6  [ -0.32% ]  Bharat Petroleum 304.5  [ 0.50% ]  Britannia Industries 4970  [ -0.82% ]  Cipla 1365  [ -1.09% ]  Coal India 425.6  [ -1.82% ]  Colgate Palm 1797.6  [ -0.69% ]  Dabur India 376.5  [ -0.26% ]  DLF 643.6  [ -1.74% ]  Dr. Reddy's Lab. 1161  [ 1.77% ]  GAIL (India) 173.9  [ -0.63% ]  Grasim Industries 3281.55  [ -1.13% ]  HCL Technologies 1207  [ 0.85% ]  HDFC Bank 708  [ 2.02% ]  Hero MotoCorp 5225  [ -1.04% ]  Hindustan Unilever 1934  [ -0.18% ]  Hindalco Industries 981.9  [ -3.64% ]  ICICI Bank 1379.15  [ -0.35% ]  Indian Hotels Co. 717.75  [ -0.38% ]  IndusInd Bank 977.8  [ -1.73% ]  Infosys 1038.2  [ 0.64% ]  ITC 260.25  [ 0.48% ]  Jindal Steel 1118.3  [ -2.08% ]  Kotak Mahindra Bank 418.7  [ 0.42% ]  L&T 3915  [ -1.01% ]  Lupin 2096  [ 1.01% ]  Mahi. & Mahi 3120  [ -0.94% ]  Maruti Suzuki India 12410  [ -0.96% ]  MTNL 24.71  [ -1.71% ]  Nestle India 1384  [ -0.86% ]  NIIT 92.4  [ -1.60% ]  NMDC 82.45  [ -2.77% ]  NTPC 333.3  [ -1.10% ]  ONGC 232.55  [ -1.88% ]  Punj. NationlBak 116.65  [ -0.17% ]  Power Grid Corpn. 269.1  [ -1.07% ]  Reliance Industries 1258  [ -1.33% ]  SBI 997  [ -0.75% ]  Vedanta 264.35  [ -1.78% ]  Shipping Corpn. 280.2  [ -1.72% ]  Sun Pharmaceutical 1842  [ -1.18% ]  Tata Chemicals 612.1  [ 0.29% ]  Tata Consumer 991.55  [ -0.83% ]  Tata Motors Passenge 302  [ 0.50% ]  Tata Steel 182.85  [ -1.67% ]  Tata Power Co. 365  [ -0.54% ]  Tata Consult. Serv. 2202  [ -0.65% ]  Tech Mahindra 1539.5  [ 1.38% ]  UltraTech Cement 10996  [ -0.52% ]  United Spirits 1397.2  [ -0.12% ]  Wipro 167.5  [ 0.81% ]  Zee Entertainment 79.43  [ -1.93% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

SOLARA ACTIVE PHARMA SCIENCES LTD.

11 September 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE624Z01016 BSE Code / NSE Code 541540 / SOLARA Book Value (Rs.) 264.83 Face Value 10.00
Bookclosure 02/04/2026 52Week High 760 EPS 0.00 P/E 0.00
Market Cap. 3600.26 Cr. 52Week Low 422 P/BV / Div Yield (%) 2.83 / 0.00 Market Lot 1.00
Security Type Other

AUDITOR'S REPORT

You can view full text of the latest Director's Report for the company.
Year End :2026-03 

We have audited the accompanying standalone financial
statements of Solara Active Pharma Sciences Limited
(the “Company"), which comprise the Balance Sheet as
at March 31, 2026, and the Statement of Profit and Loss
(including Other Comprehensive Income), the Statement
of Cash Flows and the Statement of Changes in Equity for
the year ended on that date, and notes to the standalone
financial statements, including a summary of material
accounting policies and other explanatory information.

In our opinion and to the best of our information and
according to the explanations given to us, the aforesaid
standalone financial statements give the information
required by the Companies Act, 2013 (the “Act") in
the manner so required and give a true and fair view
in conformity with the Indian Accounting Standards
prescribed under Section 133 of the Act, (“Ind AS") and
other accounting principles generally accepted in India,
of the state of affairs of the Company as at March 31,
2026, its loss and other comprehensive loss, its cash
flows and the changes in equity for the year ended on
that date.

Basis for Opinion

We conducted our audit of the standalone financial
statements in accordance with the Standards on
Auditing (“SA"s) specified under Section 143(10) of the
Act. Our responsibilities under those Standards are
further described in the Auditor's Responsibility for the
Audit of the Standalone Financial Statements section
of our report. We are independent of the Company in
accordance with the Code of Ethics issued by the Institute
of Chartered Accountants of India (“ICAI") together with
the ethical requirements that are relevant to our audit of
the standalone financial statements under the provisions
of the Act and the Rules made thereunder, and we have
fulfilled our other ethical responsibilities in accordance
with these requirements and the ICAI's Code of Ethics.
We believe that the audit evidence obtained by us is
sufficient and appropriate to provide a basis for our audit
opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our
professional judgment, were of most significance in
our audit of the standalone financial statements of the
current year. These matters were addressed in the context
of our audit of the standalone financial statements as a
whole, and in forming our opinion thereon, and we do
not provide a separate opinion on these matters. We
have determined the matters described below to be the
key audit matters to be communicated in our report.

Sr.

No.

Key Audit Matter

Auditor’s Response

i

Revenue Recognition

(Refer note 2.1 (iii) and note 26 of the standalone
financial statements)

The Company’s revenue mainly arose from sale of
pharmaceutical products, which are in the nature
of API (i.e. Active Pharmaceutical Ingredient). The
Company recognises revenue based on the terms
and conditions of transactions, which vary with
different customers.

For sales transactions in a certain period around
balance sheet date, it is essential to ensure whether
the transfer of control of the goods by the Company
to the customer occurs before the balance sheet
date or otherwise. Considering that there are
significant volume of sales transactions close to
the year end, involving material amounts and such
revenue recognition is subject to whether transfer
of control to the customer has occurred before the
balance sheet date or otherwise, we consider the
risk of revenue from sale of goods being recognised
in the incorrect period, a key audit matter.

Principal audit procedures performed included the following:

We evaluated the design of internal controls over recognition of
revenue in the appropriate period in accordance with the Company’s
accounting policy. On a sample basis, we tested the operating
effectiveness of the internal control relating to the determination of
point of time at which the transfer of control of the goods occurs.

We tested the relevant information technology systems used in
recording the revenue including Company’s system generated reports,
based on which selection of samples was undertaken.

On sample basis, we performed test of details of sales recorded close
to year end through following procedures:

- Analysed the terms and conditions of the underlying contract with
the customers; and

- Verified the evidence for the transfer of control of the goods prior
to the balance sheet date or otherwise, from relevant supporting
documents.

Sr.

No.

Key Audit Matter

Auditor’s Response

2.

Impairment assessment of Goodwill Relating to

Principal Audit Procedures performed included the following:

Human API Business and related Cash Generating
Unit (“CGU”):

Refer note 7 of the standalone financial statements.

• We assessed the Management's process for impairment
assessment of goodwill and related assets of CGU.

The Company carried Goodwill of ' 364.90 Crores

• Evaluated the design and implementation of the Management's

as at Balance Sheet date arising from past

internal control around the impairment assessment process and

Acquisitions.

As Indicated in note 2.1 (xv) to the Standalone

the related disclosure.

financial statements, the Management of the
Company assesses the Impairment of the Goodwill

• Tested the operating effectiveness of the above controls.

and related assets of CGU annually or more

• Understood the key assumptions considered in the

frequently when impairment indicators exist
The Carrying value of the Goodwill and related

Management's estimates of future cash flows.

assets of CGU will be recovered through future

• Involving our valuation specialists, we evaluated the terminal

cash flows and there is a risk of impairment loss

growth rate considered in the estimates of future cash flows and

where the actual cash flows are less than expected.
The Impairment assessment performed by the

the discount rate used in the calculations.

Management contained a number of significant

• Compared the historical cash flows (including for current year)

judgements and estimates including short and
long-term growth rates and discount rate.

We focused on this area because of the significance

against past projections of the Management for the same periods
and gained understanding of the rationale for the changes.

of the balance and the significant judgements and

• Performed sensitivity analysis on the Key assumptions within

assumptions involved in Impairment assessment
by the Management about the future results of the

the forecast cash flows and focused our attention on those

Human API Business

assumptions we considered most sensitive to the changes such
as revenue growth and profitability during the forecast period,
the terminal growth rate and discount rate applied to the future
cash flows.

• We tested management workings of the extent to which a
change in these assumptions both individually or in aggregate
would result in impairment and considered the likelihood of such
events occurring.

We further assessed the adequacy and accuracy of the disclosures
made in the standalone financial Statements for the year ended
March 31, 2026.


Information Other than the Financial Statements

and Auditor’s Report Thereon

• The Company's Board of Directors is responsible for the
other information. The other information comprises
the information included in the Board's report,
Management Discussion and Analysis, Corporate
Governance Report and Business Responsibilities
and Sustainability report but does not include
the consolidated financial statements, standalone
financial statements and our auditor's report thereon.
The Board's report, Management Discussion and
Analysis, Corporate Governance Report and Business
Responsibilities and Sustainability report is expected
to be made available to us after the date of this
auditor's report.

• Our opinion on the standalone financial statements
does not cover the other information and we will not
express any form of assurance conclusion thereon.

• In connection with our audit of the standalone
financial statements, our responsibility is to read the
other information identified above when it becomes
available and, in doing so, consider whether the
other information is materially inconsistent with the
standalone financial statements or our knowledge

obtained during the course of our audit or otherwise
appears to be materially misstated.

• When we read the Board's report, Management
Discussion and Analysis, Corporate Governance Report
and Business Responsibility and Sustainability Report,
if we conclude that there is a material misstatement
therein, we are required to communicate the matter
to those charged with governance as required under
SA 720 'The Auditor's responsibilities Relating to Other
Information'.

Responsibilities of Management and Board of
Directors for the Standalone Financial Statements

The Company's Board of Directors is responsible for the
matters stated in Section 134(5) of the Act with respect to
the preparation of these standalone financial statements
that give a true and fair view of the financial position,
financial performance including other comprehensive
income, cash flows and changes in equity of the
Company in accordance with the accounting principles
generally accepted in India, including Ind AS specified
under Section 133 of the Act. This responsibility
also includes maintenance of adequate accounting
records in accordance with the provisions of the Act
for safeguarding the assets of the Company and for
preventing and detecting frauds and other irregularities;

selection and application of appropriate accounting
policies; making judgments and estimates that are
reasonable and prudent; and design, implementation
and maintenance of adequate internal financial controls,
that were operating effectively for ensuring the accuracy
and completeness of the accounting records, relevant
to the preparation and presentation of the financial
statements that give a true and fair view and are free
from material misstatement, whether due to fraud
or error.

In preparing the standalone financial statements,
Management and Board of Directors are responsible for
assessing the Company's ability to continue as a going
concern, disclosing, as applicable, matters related to
going concern and using the going concern basis of
accounting unless the Board of Directors either intend
to liquidate the Company or to cease operations, or has
no realistic alternative but to do so.

The Company's Board of Directors is also responsible for
overseeing the Company's financial reporting process.

Auditor’s Responsibility for the Audit of the
Standalone Financial Statements

Our objectives are to obtain reasonable assurance
about whether the standalone financial statements as
a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor's report that
includes our opinion. Reasonable assurance is a high
level of assurance, but is not a guarantee that an audit
conducted in accordance with SAs will always detect
a material misstatement when it exists. Misstatements
can arise from fraud or error and are considered
material if, individually or in the aggregate, they could
reasonably be expected to influence the economic
decisions of users taken on the basis of these standalone
financial statements.

As part of an audit in accordance with SAs, we exercise
professional judgment and maintain professional
skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement
of the standalone financial statements, whether due
to fraud or error, design and perform audit procedures
responsive to those risks, and obtain audit evidence
that is sufficient and appropriate to provide a basis
for our opinion. The risk of not detecting a material
misstatement resulting from fraud is higher than for
one resulting from error, as fraud may involve collusion,
forgery, intentional omissions, misrepresentations, or
the override of internal control.

• Obtain an understanding of internal financial controls
relevant to the audit in order to design audit procedures
that are appropriate in the circumstances. Under
Section 143(3)(i) of the Act, we are also responsible for
expressing our opinion on whether the Company has
adequate internal financial controls with reference
to standalone financial statements in place and the
operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies
used and the reasonableness of accounting estimates
and related disclosures made by the Management.

• Conclude on the appropriateness of Management's
use of the going concern basis of accounting and,
based on the audit evidence obtained, whether
a material uncertainty exists related to events or
conditions that may cast significant doubt on the
Company's ability to continue as a going concern. If
we conclude that a material uncertainty exists, we
are required to draw attention in our auditor's report
to the related disclosures in the standalone financial
statements or, if such disclosures are inadequate, to
modify our opinion. Our conclusions are based on
the audit evidence obtained up to the date of our
auditor's report. However, future events or conditions
may cause the Company to cease to continue as a
going concern.

• Evaluate the overall presentation, structure and content
of the standalone financial statements, including the
disclosures, and whether the standalone financial
statements represent the underlying transactions and
events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the
standalone financial statements that, individually or
in aggregate, makes it probable that the economic
decisions of a reasonably knowledgeable user of the
standalone financial statements may be influenced.
We consider quantitative materiality and qualitative
factors in (i) planning the scope of our audit work and in
evaluating the results of our work; and (ii) to evaluate the
effect of any identified misstatements in the standalone
financial statements.

We communicate with those charged with governance
regarding, among other matters, the planned scope
and timing of the audit and significant audit findings,
including any significant deficiencies in internal financial
controls that we identify during our audit.

We also provide those charged with governance with
a statement that we have complied with relevant
ethical requirements regarding independence, and to
communicate with them all relationships and other
matters that may reasonably be thought to bear on our
independence, and where applicable, related safeguards.

From the matters communicated with those charged
with governance, we determine those matters that
were of most significance in the audit of the standalone
financial statements of the current period and are
therefore the key audit matters. We describe these
matters in our auditor's report unless law or regulation
precludes public disclosure about the matter or when,
in extremely rare circumstances, we determine that
a matter should not be communicated in our report
because the adverse consequences of doing so would
reasonably be expected to outweigh the public interest
benefits of such communication.

REPORT ON OTHER LEGAL AND REGULATORY
REQUIREMENTS

1. As required by Section 143(3) of the Act, based on

our audit we report that:

a) We have sought and obtained all the
information and explanations which to the best
of our knowledge and belief were necessary for
the purposes of our audit.

b) In our opinion, proper books of account as
required by law have been kept by the Company
so far as it appears from our examination of
those books, except for not complying with
the requirement of audit trail as stated in (i)
(vi) below.

c) The Balance Sheet, the Statement of Profit and
Loss including Other Comprehensive Income,
the Statement of Cash Flows and Statement
of Changes in Equity dealt with by this Report
are in agreement with the relevant books
of account.

d) In our opinion, the aforesaid standalone
financial statements comply with the Ind AS
specified under Section 133 of the Act.

e) On the basis of the written representations
received from the directors as on March 31,
2026 taken on record by the Board of Directors,
none of the directors is disqualified as on March
31, 2026 from being appointed as a director in
terms of Section 164(2) of the Act.

f) The modification relating to the maintenance
of accounts and other matters connected
therewith, is as stated in paragraph (b) above.

g) With respect to the adequacy of the internal
financial controls with reference to standalone
financial statements of the Company and the
operating effectiveness of such controls, refer
to our separate Report in “Annexure A". Our
report expresses an unmodified opinion on
the adequacy and operating effectiveness of
the Company's internal financial controls with
reference to standalone financial statements.

h) With respect to the other matters to be included
in the Auditor's Report in accordance with the
requirements of Section 197(16) of the Act, as
amended, in our opinion and to the best of our
information and according to the explanations
given to us, the remuneration paid by the
Company to its directors during the year is in
accordance with the provisions of Section 197
of the Act.

i) With respect to the other matters to be included

in the Auditor's Report in accordance with Rule
11 of the Companies (Audit and Auditors) Rules,
2014, as amended in our opinion and to the
best of our information and according to the
explanations given to us:

i. The Company has disclosed the impact of
pending litigations on its financial position
in its standalone financial statements
- Refer note 37 to the standalone
financial statements.

ii. The Company did not have any long-term
contracts including derivative contracts
for which there were any material
foreseeable losses.

iii. There has been no delay in transferring
amounts, required to be transferred, to the
Investor Education and Protection Fund by
the Company.

iv. (a) The Management has represented

that, to the best of its knowledge and
belief, as disclosed in the note 47(h) to
the standalone financial statements
no funds have been advanced
or loaned or invested (either from
borrowed funds or share premium
or any other sources or kind of funds)
by the Company to or in any other
person(s) or entity(ies), including
foreign entities (“Intermediaries"),
with the understanding, whether
recorded in writing or otherwise,
that the Intermediary shall, directly
or indirectly lend or invest in other
persons or entities identified in
any manner whatsoever by or on
behalf of the Company (“Ultimate
Beneficiaries") or provide any
guarantee, security or the like on
behalf of the Ultimate Beneficiaries.

(b) The Management has represented,
that, to the best of its knowledge and
belief, as disclosed in the note 47(i) to
the standalone financial statements,
no funds have been received by
the Company from any person(s)
or entity(ies), including foreign
entities (“Funding Parties"), with the
understanding, whether recorded in
writing or otherwise, that the Company
shall, directly or indirectly, lend or
invest in other persons or entities
identified in any manner whatsoever

by or on behalf of the Funding Party
(“Ultimate Beneficiaries") or provide
any guarantee, security or the like on
behalf of the Ultimate Beneficiaries.

(c) Based on the audit procedures
performed that have been considered
reasonable and appropriate in the
circumstances, nothing has come
to our notice that has caused us to
believe that the representations under
sub-clause (i) and (ii) of Rule 11(e), as
provided under (a) and (b) above,
contain any material misstatement.

v. The Company has not declared or paid
any dividend during the year and has not
proposed final dividend for the year.

vi. Based on our examination, which
included test checks, the Company has
used accounting software systems for
maintaining its books of account for
the financial year ended March 31, 2026
which have the feature of recording
audit trail (edit log) facility and the same
has operated throughout the year for all
relevant transactions recorded in the
software except that in respect of one
accounting software, audit trail was not

enabled for certain critical tables (refer note
48 to the standalone financial statements).
Accordingly, we are unable to comment
on whether there was any instance of the
audit trail feature being tampered with.

Additionally, the audit trail that was
enabled and operated has been preserved
by the Company as per the statutory
requirements for record retention, as
stated in Note 48 to the standalone
financial statements.

2. As required by the Companies (Auditor's Report)
Order, 2020 (“the Order") issued by the Central
Government in terms of Section 143(11) of the Act,
we give in “Annexure B" a statement on the matters
specified in paragraphs 3 and 4 of the Order.

For DELOITTE HASKINS & SELLS LLP

Chartered Accountants
(Firm’s Registration No. 117366W/W-100018)

Sandeep Kukreja

(Partner)

(Membership No. 220411)
(UDIN: 26220411ZVQSGU3720)

Place: Bengaluru

Date: May 15, 2026